Tang, X., Chen, Y., Zhu, Y., Liu, Y., Li, W., Wang, W., & Wang, Z. (2026). Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidence. Clinical Medicine Insights: Oncology, 20, 1-18.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Tang, Xiumei, Yanmei Chen, Yuan Zhu, Yuan Liu, Weimin Li, Wenzhao Wang, and Zhoufeng Wang. "Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidence."
Clinical Medicine Insights: Oncology 20 (2026): 1-18.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Tang, Xiumei, et al. "Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidence."
Clinical Medicine Insights: Oncology, vol. 20, 2026, pp. 1-18.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.